ReviewNeurology research international2026
Enhanced Recovery Protocol Post-TBI (ERA-TBI): Factors Determining Morbidity and Mortality.
Review in Neurology research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhanced Recovery Protocol Post-TBI (ERA-TBI): Factors Determining Morbidity and Mortality.Neurology research international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI) remains a leading cause of death and long-term disability worldwide, with substantial heterogeneity in recovery trajectories despite advances in acute neurocritical care. Enhanced Recovery After Surgery (ERAS) programmes, which integrate evidence-based, multidisciplinary perioperative care bundles, have demonstrated consistent benefits across multiple surgical specialities and emerging promise in neurosurgical populations. However, the application of enhanced recovery principles to the recovery phase following TBI remains fragmented and insufficiently synthesised. This narrative review examines recovery-phase factors influencing morbidity and mortality after TBI within the conceptual framework of Enhanced Recovery After TBI (ERA-TBI). Focussing specifically on postacute recovery, we synthesise evidence across three interrelated domains: rehabilitation strategies, patient demographics and preexisting conditions. Perioperative surgical techniques and acute intensive care management are considered only insofar as they contextualise recovery-phase outcomes. The reviewed literature demonstrates that early, intensive and multidisciplinary rehabilitation, particularly early mobilisation and structured cognitive or neuropsychological interventions, is associated with improved neurological recovery, functional independence, quality of life and reduced hospital length of stay, without evidence of increased mortality. Emerging technologies, including virtual reality and telerehabilitation, show promising cognitive and functional benefits, although evidence remains limited by heterogeneity and small sample sizes. Patient-level factors strongly modify recovery potential: advanced age, frailty and socioeconomic disadvantage consistently predict poorer outcomes, while access to high-intensity inpatient rehabilitation is a key mediator of morbidity. Preexisting metabolic, cardiovascular and neuropsychiatric comorbidities further exacerbate secondary brain injury, prolong hospitalisation and increase postdischarge mortality risk. Overall, ERA-TBI pathways must move beyond uniform care bundles towards stratified, patient-centred recovery models that integrate biological reserve, social context and comorbidity burden. Standardising the recovery phase through an ERA-TBI framework offers a critical opportunity to reduce variability in outcomes, optimise functional recovery and address the growing global burden of TBI-related disability.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.